Catalyst
Slingshot members are tracking this event:
Neurocrine's (NBIX) Phase 2 T-Force Green Results Evaluating Ingrezza in Adults with Tourette Syndrome due in Early 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NBIX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 17, 2017
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=68817&p=irol-newsArticle&ID=2237914
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, T-force Green, Ingrezza, Pediatrics, Tourette Syndrome
